Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims
One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood pressure medication. The U.S. District Judge presiding over the valsartan lawsuits has been informed that a preliminary settlement agreement has been reached with Hetero Drugs, […]
Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »